86 studies found for:    cholangiocarcinoma | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Radiation: Therasphere® in association with Gemcitabine and Cisplatin
22 Recruiting A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
Condition: Cholangiocarcinoma
Interventions: Drug: Amphinex and Gemcitabine;   Drug: Gemcitabine and Cisplatin
23 Recruiting Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma
Condition: Hilar Cholangiocarcinoma
Intervention: Other: liver transplantation combined with neoadjuvant therapy
24 Recruiting Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
Conditions: Intrahepatic Cholangiocarcinoma;   Peripheral Cholangiocarcinoma;   Cholangiolar Carcinoma;   Cholangiocellular Carcinoma
Interventions: Drug: Floxuridine (FUDR);   Drug: dexamethasone;   Drug: Gemcitabine;   Drug: Oxaliplatin;   Other: MRI;   Other: Research blood draws
25 Recruiting Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Morphological Diagnosis of Hilar Cholangiocarcinoma (Excluded Type 1), Resectable With Expected R0 Margins on an intent-to Treat Basis.
Interventions: Procedure: CAPECITABINE-Radiotherapy -Liver Transplantation;   Procedure: RESECTION
26 Recruiting Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma
Conditions: Intrahepatic Cholangiocarcinoma;   Peripheral Cholangiocarcinoma;   Cholangiolar Carcinoma;   Cholangiocellular Carcinoma) (ICC)
Interventions: Procedure: Liver resection and placement of hepatic artery infusion pump;   Drug: FLOXURIDINE;   Drug: DEXAMETHASONE;   Drug: GEMCITABINE
27 Recruiting Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma
Conditions: Solid Tumors;   Thyroid Cancer;   Soft-tissue Sarcoma;   Cholangiocarcinoma
Interventions: Drug: Pazopanib;   Drug: GSK1120212
28 Recruiting A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
Condition: Metastatic Biliary Tract Carcinoma
Intervention: Drug: Regorafenib
29 Recruiting Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).
Condition: Intrahepatic Cholangiocellular Carcinoma
Interventions: Procedure: DEB TACE;   Procedure: SIRT
30 Recruiting A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
Condition: Cholangiocarcinoma
Intervention: Drug: Gemcitabine
31 Recruiting Regorafenib Versus Placebo to Treat Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: Regorafenib/active;   Drug: Regorafenib/placebo
32 Recruiting Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma.
Condition: Cholangiocellular Carcinoma
Intervention: Drug: Cisplatin and Gemcitabine
33 Recruiting RFA RCT for Pancreatic or Bile Duct Cancer
Conditions: Unresectable Pancreatic Cancer;   Cholangiocarcinoma Non-resectable
Interventions: Procedure: Radiofrequency Ablation using EndoHPB Probe;   Procedure: Stenting only
34 Recruiting IRS(Irradiation Stent) vs. CS(Conventional Stent) Insertion in Inoperable Malignant Biliary Obstruction
Condition: Cholangiocarcinoma
Interventions: Procedure: Stenting;   Device: self-expandable metallic biliary stent loaded with 125 iodine seeds;   Device: conventional biliary self-expandable stent;   Procedure: brachytherapy
35 Recruiting Endobiliary RFA for Unresectable Malignant Biliary Strictures
Conditions: Cholangiocarcinoma;   Ampullary Carcinoma
Intervention: Procedure: Radiofrequency ablation (RFA)
36 Recruiting Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases
Conditions: Liver Cancer;   Metastatic Cancer
Interventions: Drug: capecitabine;   Radiation: yttrium Y 90 glass microspheres
37 Recruiting Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin
Condition: Unresectable Intrahepatic Cholangiocarcinoma
Interventions: Device: LC Bead with Gem-Cis;   Drug: Gemcitabine and Cisplatin
38 Unknown  Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma
Conditions: Metastatic Liver Cancer;   Cholangiocarcinoma;   Neoplasm Metastasis
Intervention: Procedure: Irreversible electroporation (IRE)
39 Recruiting Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy
Condition: Cholangiocellular Carcinoma
Intervention: Drug: Selective intra-arterial floxuridine and systemic gemcitabine and cisplatin
40 Recruiting Treatment for Bile Duct Cancer in the Liver
Condition: Cholangio Carcinoma
Intervention: Drug: SIRT Yttrium-90

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years